Humana Inc.'s stock closed down another 1.9% on Thursday to bring its week-to-date losses to 24.3%, after BofA Securities downgraded it to underperform - or sell - on concerns about a delay in margin ...

Another significant legal headache related to star ratings is on the table of the federal government just days before open ...

Annual National Conference was held Sep. 4-6 in Orlando, Florida. Managed Healthcare Executive is the official publication of ...

Humana's (HUM) 2026 financial results are likely to see a "significant headwind" from potentially losing its 2025 Medicare Advantage quality star ratings, BofA Securities said in a note e-mailed ...

Humana (HUM) stock fell as Piper Sandler cut rating due to a sharp drop in top-rated Medicare plan enrollments that led to a ...

With partners including UChicago Medicine, Endeavor Health and Duly, Essence Healthcare aims to take advantage of an ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

Humana's stock took a tumble after the provider admitted to the SEC that only about 1 in 4 of its members were signed up to Medicare Advantage plans rated four stars or more. Meanwhile, CMS is making ...

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Baxter from ...

Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...

The stock slid more than 10% as the health insurer warned that a steep drop in the federal government’s quality ratings of ...